U.S. flag

An official website of the United States government

NM_002667.5(PLN):c.73C>G (p.Arg25Gly) AND Dilated cardiomyopathy 1P

Germline classification:
Uncertain significance (1 submission)
Last evaluated:
Sep 4, 2023
Review status:
1 star out of maximum of 4 stars
criteria provided, single submitter
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV001852372.6

Allele description [Variation Report for NM_002667.5(PLN):c.73C>G (p.Arg25Gly)]

NM_002667.5(PLN):c.73C>G (p.Arg25Gly)

Genes:
CEP85L:centrosomal protein 85 like [Gene - OMIM - HGNC]
PLN:phospholamban [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
6q22.31
Genomic location:
Preferred name:
NM_002667.5(PLN):c.73C>G (p.Arg25Gly)
Other names:
p.R25G:CGT>GGT
HGVS:
  • NC_000006.12:g.118558994C>G
  • NG_009082.1:g.15716C>G
  • NG_021248.1:g.156082G>C
  • NM_001042475.3:c.1020+6535G>CMANE SELECT
  • NM_001178035.2:c.1029+6535G>C
  • NM_002667.5:c.73C>GMANE SELECT
  • NM_206921.3:c.1020+6535G>C
  • NP_002658.1:p.Arg25Gly
  • NP_002658.1:p.Arg25Gly
  • LRG_390t1:c.73C>G
  • LRG_390:g.15716C>G
  • LRG_390p1:p.Arg25Gly
  • NC_000006.11:g.118880157C>G
  • NM_002667.3:c.73C>G
Protein change:
R25G
Links:
dbSNP: rs761056344
NCBI 1000 Genomes Browser:
rs761056344
Molecular consequence:
  • NM_001042475.3:c.1020+6535G>C - intron variant - [Sequence Ontology: SO:0001627]
  • NM_001178035.2:c.1029+6535G>C - intron variant - [Sequence Ontology: SO:0001627]
  • NM_206921.3:c.1020+6535G>C - intron variant - [Sequence Ontology: SO:0001627]
  • NM_002667.5:c.73C>G - missense variant - [Sequence Ontology: SO:0001583]

Condition(s)

Name:
Dilated cardiomyopathy 1P (CMD1P)
Identifiers:
MONDO: MONDO:0012362; MedGen: C1835928; Orphanet: 154; OMIM: 609909

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV002144493Labcorp Genetics (formerly Invitae), Labcorp
criteria provided, single submitter

(Invitae Variant Classification Sherloc (09022015))
Uncertain significance
(Sep 4, 2023)
germlineclinical testing

PubMed (4)
[See all records that cite these PMIDs]

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing

Citations

PubMed

Role of common and rare variants in SCN10A: results from the Brugada syndrome QRS locus gene discovery collaborative study.

Behr ER, Savio-Galimberti E, Barc J, Holst AG, Petropoulou E, Prins BP, Jabbari J, Torchio M, Berthet M, Mizusawa Y, Yang T, Nannenberg EA, Dagradi F, Weeke P, Bastiaenan R, Ackerman MJ, Haunso S, Leenhardt A, Kääb S, Probst V, Redon R, Sharma S, et al.

Cardiovasc Res. 2015 Jun 1;106(3):520-9. doi: 10.1093/cvr/cvv042. Epub 2015 Feb 17. Erratum in: Cardiovasc Res. 2016 May 1;110(1):3. doi: 10.1093/cvr/cvw038.

PubMed [citation]
PMID:
25691538
PMCID:
PMC4447806

A novel human R25C-phospholamban mutation is associated with super-inhibition of calcium cycling and ventricular arrhythmia.

Liu GS, Morales A, Vafiadaki E, Lam CK, Cai WF, Haghighi K, Adly G, Hershberger RE, Kranias EG.

Cardiovasc Res. 2015 Jul 1;107(1):164-74. doi: 10.1093/cvr/cvv127. Epub 2015 Apr 7.

PubMed [citation]
PMID:
25852082
PMCID:
PMC4490203
See all PubMed Citations (4)

Details of each submission

From Labcorp Genetics (formerly Invitae), Labcorp, SCV002144493.3

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (4)

Description

This variant is present in population databases (rs761056344, gnomAD 0.0009%). This sequence change replaces arginine, which is basic and polar, with glycine, which is neutral and non-polar, at codon 25 of the PLN protein (p.Arg25Gly). This variant has not been reported in the literature in individuals affected with PLN-related conditions. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. This variant disrupts the p.Arg25 amino acid residue in PLN. Other variant(s) that disrupt this residue have been determined to be pathogenic (PMID: 25691538, 25852082, 30012837; Invitae). This suggests that this residue is clinically significant, and that variants that disrupt this residue are likely to be disease-causing. An algorithm developed to predict the effect of missense changes on protein structure and function (PolyPhen-2) suggests that this variant is likely to be disruptive. ClinVar contains an entry for this variant (Variation ID: 202038).

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Sep 29, 2024